Validation of Immunoassay-Based Tools for the Comprehensive Quantification of Aβ(40) and Aβ(42) Peptides in Plasma

Recent advances in neuroimaging and cerebrospinal fluid (CSF) biomarker assays have provided evidence of a long preclinical stage of Alzheimer’s disease (AD). This period is being increasingly targeted for secondary prevention trials of new therapies. In this context, the interest of a noninvasive,...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Grijalba, Virginia, Fandos, Noelia, Canudas, Jesús, Insua, Daniel, Casabona, Diego, Lacosta, Ana M., Montañés, María, Pesini, Pedro, Sarasa, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044780/
https://www.ncbi.nlm.nih.gov/pubmed/27567833
http://dx.doi.org/10.3233/JAD-160325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044780/
https://www.ncbi.nlm.nih.gov/pubmed/27567833
http://dx.doi.org/10.3233/JAD-160325

Ejemplares similares